Trial record 1 of 1 for:    CYC-682-12
Previous Study | Return to List | Next Study

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (SEAMLESS)

This study is currently recruiting participants.
Verified September 2012 by Cyclacel Pharmaceuticals, Inc.
Sponsor:
Information provided by (Responsible Party):
Cyclacel Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT01303796
First received: February 21, 2011
Last updated: March 25, 2014
Last verified: September 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2015
  Estimated Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)